Malignant neoplasms associated with HIV infection. Problems and solutions (problem outline)
- Authors: Kaprin A.D.1, Voronin E.E.2, Rassokhin V.V.3,4, Rozenberg V.V.2, Nekrasova A.V.5, Falaleeva N.A.1, Ivanov S.A.1, Grivtsova L.Y.1
-
Affiliations:
- National Medical Research Radiological Centre
- Republican Clinical Infectious Diseases Hospital
- Northwest District AIDS Prevention and Control Center of Pasteur Research Institute of Epidemiology and Mictobiology
- Pavlov First Saint Petersburg State Medical University
- Moscow Regional Oncology Center
- Issue: Vol 23, No 3 (2021)
- Pages: 502-507
- Section: CLINICAL ONCOLOGY
- URL: https://journals.rcsi.science/1815-1434/article/view/80666
- DOI: https://doi.org/10.26442/18151434.2021.3.201041
- ID: 80666
Cite item
Full Text
Abstract
HIV infection refers to socially significant diseases. As a result of the wide coverage of effective antiretroviral therapy for people living with HIV, the rates of AIDS-related mortality have significantly decreased. At the same time, there was a noticeable increase in morbidity and mortality from other non-AIDS-related diseases, not the last place in this list is occupied by malignant neoplasms. A decrease in the frequency of AIDS-associated tumors and an increase in the proportion of AIDS-unassociated tumors are significant changes in the structure of malignant neoplasms. There is a complex relationship between HIV-induced immune suppression, chronic antigenic stimulation and concomitant oncogenic viral infections, which increases the risk of developing malignant tumors in these patients. People living with HIV have higher rates of cancer mortality associated with both the lack of adequate antitumor therapy, complications of treatment, and the existence of a direct relationship between immunosuppression and tumor progression. This article analyzes the problems that arise in the treatment of oncological HIV-infected patients, and offers specific practical steps to solve complex interdisciplinary problems.
Full Text
##article.viewOnOriginalSite##About the authors
Andrei D. Kaprin
National Medical Research Radiological Centre
Email: grivtsova@mail.ru
ORCID iD: 0000-0001-8784-8415
D. Sci. (Med.), Prof., Acad. RAS
Russian Federation, ObninskEvgenii E. Voronin
Republican Clinical Infectious Diseases Hospital
Email: grivtsova@mail.ru
ORCID iD: 0000-0001-7547-6407
D. Sci. (Med.), Prof.
Russian Federation, Saint PetersburgVadim V. Rassokhin
Northwest District AIDS Prevention and Control Center of Pasteur Research Institute of Epidemiology and Mictobiology; Pavlov First Saint Petersburg State Medical University
Email: grivtsova@mail.ru
ORCID iD: 0000-0002-1159-0101
D. Sci. (Med.), Prof.
Russian Federation, Saint PetersburgVladimir V. Rozenberg
Republican Clinical Infectious Diseases Hospital
Email: grivtsova@mail.ru
ORCID iD: 0000-0002-4966-9691
Cand. Sci. (Med.)
Russian Federation, Saint PetersburgAnastasyia V. Nekrasova
Moscow Regional Oncology Center
Email: grivtsova@mail.ru
ORCID iD: 0000-0002-0016-2531
oncologist
Russian Federation, MoscowNatalia A. Falaleeva
National Medical Research Radiological Centre
Email: grivtsova@mail.ru
ORCID iD: 0000-0002-0023-4216
D. Sci. (Med.)
Russian Federation, ObninskSergei A. Ivanov
National Medical Research Radiological Centre
Email: grivtsova@mail.ru
ORCID iD: 0000-0001-7689-6032
D. Sci. (Med.), Prof. RAS
Russian Federation, ObninskLyudmila Y. Grivtsova
National Medical Research Radiological Centre
Author for correspondence.
Email: grivtsova@mail.ru
ORCID iD: 0000-0001-9103-9688
D. Sci. (Biol.)
Russian Federation, ObninskReferences
- Рассохин В.В., Некрасова А.В., Беляков Н.А. Злокачественные опухоли при ВИЧ-инфекции. Локализация, профилактика, лечение. Часть 2. ВИЧ-инфекция и иммуносупрессии. 2017;9(2):16-26 [Rassokhin VV, Nekrasova AV, Belyakov NA. Zlokachestvennyye opukholi pri VICH-infektsii. Lokalizatsiya, profilaktika, lecheniye. Chast 2. VICH-infektsiya i immunosupressii. 2017;9(2):16-26 (in Russian)]. doi: 10.22328/2077-9828-2017-9-2-16-26
- Некрасова А.В., Леонова О.Н., Рассохин В.В., и др. Особенности развития злокачественных опухолей у пациентов с ВИЧ-инфекцией в Санкт-Петербурге. ВИЧ-инфекция и иммуносупрессии. 2014;8(1):31-41 [Nekrasova AV, Leonova ON, Rassokhin VV, et al. Osobennosti razvitiya zlokachestvennykh opukholey u patsiyentov s VICH-infektsiyey v Sankt-Peterburge. VICH-infektsiya i immunosupressii. 2014;8(1):31-41 (in Russian)]. doi: 10.22328/2077-9828-2016-8-1-31-41
- Shiels M, Pfeiffer R, Gai MH, et al. Cancer burden in the HIV-infected population in the United States. Journal of the National Cancer Institute. 2011;103(9):753-62. doi: 10.1093/jnci/djr076
- Simard EP, Pfeiffer RM, Engels EA. Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med. 2010;170(15):1337-45. doi: 10.1001/archinternmed.2010.253
- Gopal S, Achenbach CJ, Yanik EL, et al. Moving forward in HIV-associated cancer. J Clin Oncol. 2014;32(9):876-80. doi: 10.1200/JCO.2013.53.1376
- Flepisi BT, Bouic P, Sissolak G, Rosenkranz B. Drug-drug interactions in HIV positive cancer patients. Biomed Pharmacother. 2014;68(5):665-77. doi: 10.1016/j.biopha.2014.04.010
- Рассохин В.В., Леонова О.Н., Беляков Н.А., и др. Частота и характер онкологических заболеваний у больных с ВИЧ-инфекцией до и на фоне применения высокоактивной антиретровирусной терапии. ВИЧ-инфекция и иммуносупрессии. 2012;4(4):34-43 [Rassokhin VV, Leonova ON, Belyakov NA, et al. Chastota i kharakter onkologicheskikh zabolevaniy u bolnykh s VICH-infektsiyey do i na fone primeneniya vysokoaktivnoy antiretrovirusnoy terapii. VICH-infektsiya i immunosupressii. 2012;4(4):34-43 (in Russian)].
- Gérard JP, Aubert B, Buchheit I, et al. Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy. Cancer Radiother. 2012;16 Suppl:S5-9. doi: 10.1016/j.canrad.2011.07.248
- Llibre JM, Falco V, Tural C, et al. The changing face of HIV/AIDS in treated patients. Curr HIV Res. 2009;7(4):365-77. doi: 10.2174/157016209788680633
- Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS. 2014;28(4):453-65. doi: 10.1097/QAD.0000000000000071
- Трофимова Т.Н., Беляков Н.А., Рассохин В.В. Радиология и ВИЧ-инфекция. СПб.: Балтийский медицинский образовательный центр, 2017 [Trofimova TN, Belyakov NA, Rassokhin VV. Radiologiia i VICh-infektsiia. Saint Petersburg: Baltiiskii meditsinskii obrazovatel'nyi tsentr, 2017 (in Russian)].
- The proportion of suspected malaria cases receiving a malaria diagnostic test has increased markedly since 2010, especially in the WHO African Region. Available at: https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/deaths Accessed: 13.12.2020
- Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48(5):590-8. doi: 10.1097/QAI.0b013e31817efb54
- Официальная статистика ВИЧ, СПИДа в России. Режим доступа: https://spid-vich-zppp.ru/statistika/ofitsialnaya-statistika-vich-spid-rf-2016.html. Ссылка активна на 13.12.2020 [Official statistics of HIV, AIDS in Russia. Available at: https://spid-vich-zppp.ru/statistika/ofitsialnaya-statistika-vich-spid-rf-2016.html. Accessed: 13.12.2020 (in Russian)].
- Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. J Clin Oncol. 2015;33(21):2376-83. doi: 10.1200/JCO.2014.59.5967
- Беляков Н.А., Рассохин В.В., Трофимова Т.Н. Коморбидные и тяжелые формы ВИЧ-инфекции в России. ВИЧ-инфекция и иммуносупрессии. 2015;8(3):9-21. [Belyakov NA, Rassokhin VV, Trofimova TN. Komorbidnyye i tyazhelyye formy VICH-infektsii v Rossii. VICH-infektsiya i immunosupressii. 2015;8(3):9-21 (in Russian)]. doi: 10.22328/2077-9828-2016-8-3-9-25
- Бердичевский В.Б., Быкова И.Н., Соколова Е.В., и др. Ситуация по ВИЧ-инфекции в Российской Федерации. Терапевтический архив. 2013;85(11):10-5 [Berdichevskiy VB, Bykova IN, Sokolova YeV, et al. Situation with HIV infection in the Russian Federation. Terapevticheskii Arkhiv (Ter. Arkh.). 2013;85(11):10-5 (in Russian)].
- Suneja G, Lin CC, Simard EP, et al. Disparities in cancer treatment among patients infected with the human immunodeficiency virus. Cancer. 2016;122(15):2399-407. doi: 10.1002/cncr.30052
- Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009;27(6):884-90. doi: 10.1200/JCO.2008.19.6626
- Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS. 2006;20(12):1645-54. doi: 10.1097/01.aids.0000238411.75324.59